Use of the cytokine IP-10 as an anti-tumor agent
US6153600A · kind A · utility
2Cited by
4References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 4, 1999 |
| Grant date | Nov 28, 2000 |
| Priority date | — |
| Expiry date | Jun 4, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and therapeutic compositions for inhibiting neoplasms by administration of a nucleic acid sequence encoding the IP-10 polypeptide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.